Skip to main content

WEBINAR: Safety Surveillance through Antiretroviral Pregnancy Registry

Thank you

This live web event has ended. Thank you for attending.

Description


Safety Surveillance through Antiretroviral Pregnancy Registry 

Learning Objectives:
  • Describe the objectives of the Antiretroviral Pregnancy Registry (APR)
  • List key findings from analysis of APR data
  • Describe four steps to report a drug exposure to the APR
  • Identify early warning signals of major tetrogenicity¬†

Contributors

  • William Short, MD, MPH, FIDSA, AAHIVS

    Associate Professor
    Perelman School of Medicine 
    University of Pennsylvania

  • Lynne M. Mofenson, MD

    Senior HIV Technical Advisory
    Elizabeth Glaser Pediatric AIDS Foundation

  • Angela Scheuerle, MD, FAAP, FACMG

    Professor, Department of Pediatrics, Division of Genetic and Metabolism Director, UTSW Rare Disease Center of Excellence University of Texas Southwestern Medical

  • Jessica Albano, PhD, MPH

    Vice President, Epidemiology and Analytics
    Syneos Health

May 13, 2022
Fri 3:00 PM EDT

Duration 1H 0M

This live web event has ended.

For Technical Support
+1 (858) 201-4136